Search

everythinglearnresearchcommunity

for

Search:↓

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

A new method to make Finasteride is more cost-effective and yields 16%.

New steroid derivatives show promise as anticancer agents, even against resistant cells.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

A new method accurately measures DHEAS in blood, improving on current tests.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

A quick method effectively detects banned substances in urine.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

New compounds with carborane showed anti-androgen effects similar to flutamide.

The treatment improved acne, seborrhoea, and hirsutism, with some side effects like spotting and nervousness.

Many black market drugs for bodybuilders are fake and mislabeled.

A new method to make finasteride for hair loss treatment was developed.

DHEA supplementation may improve quality of life, neuropsychological functions, and sexual satisfaction in individuals with adrenal insufficiency, but more research is needed to confirm its safety and effectiveness.

The new method makes finasteride cheaper and easier to produce.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

3α-androstanediol helps reduce age-related cognitive and mood declines in male rats, unlike testosterone.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Blocking 11β-HSD1 can lessen the harmful effects of glucocorticoids on hair growth cells.

A new method accurately measures nine neuroactive steroids in small blood samples, helping to study brain diseases.

Canine hair follicle cells metabolize DHEA and testosterone differently than human cells.

Neogynon effectively prevents pregnancy but may cause side effects like headaches and menstrual changes.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

TrichoFoam™ is a stable option for personalized hair loss treatment with most ingredients remaining effective for 90-180 days.

New compounds may help treat prostate cancer by reducing cell growth.